Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...

With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

Lizzo revealed on the 'Just Trish' podcast on June 19 that she has tried Ozempic and other GLP-1 drugs — which are ...

At last week’s Flow Space Women’s Health Forum, triple board-certified endocrinologist Dr. Rocio Salas-Whalen sat before a ...

T he increasing use of GLP-1 medications for weight loss has triggered a corresponding surge in body lift surgeries, as ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Ohio to end GLP-1 drug coverage for most state workers without diabetes, citing soaring Medicaid costs and rising demand for ...